Xonar Technology Inc., developer of next-generation contactless security screening systems, has named Paul Sarnese, a leading healthcare security consultant, to the company’s advisory board. Sarnese joins prominent leaders and technology experts on Xonar®’s advisory board as the company launches its AI-empowered TruePort® screening devices in sports venues and other facilities. Sarnese’s experience will be pivotal as Xonar supports California healthcare fac

Instinct Science, a leader in veterinary software innovation, announces the launch of Standards of Care™,  a next-generation clinical decision support tool designed to provide veterinary professionals with peer-reviewed, real-world guidance at the point of care. With Plumb’s® at its core, Standards™ is the only continually updated resource for veterinarians that consolidates the latest veterinary medical knowledge into a practical, searchable, peer-reviewe

WORK Medical Technology Group LTD, a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd. (“Chartwell Medical”), a high-end medical products manufacturer across diverse fields, including nuclear medicine, imaging, infection control, ophthalmology, and rehabilitation robotics, to drive industrial synergy and ac

Demetra Holding, an innovative and independent international medical company leader in providing anti-infective cements, spacers and biomaterials for orthopedic applications, today announced its acquisition of a 51% stake in GetSet Surgical, a leading Swiss-based spine surgical solutions provider. The acquisition marks a significant step in Demetra Holding's strategy to broaden its offerings in the Spine sector. The collaboration will combine Demetra’s existing technologies with Get

Prime Healthcare announced today that it has successfully completed the historic acquisition of eight Ascension Illinois hospitals, four senior living and post-acute care facilities, and physician practices, signaling a new era of service excellence and award-winning healthcare in the Greater Chicago area. After an extensive review process, the Illinois Health Facilities and Services Review Board voted unanimously to approve the acquisition and the Archdiocese of Chicago and the Vatican grant

Astrana Health, Inc. a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, is participating in the following upcoming investor conferences: The TD Cowen 45th Annual Health Care Conference, being held in Boston, on Monday, March 3, 2025, including a fireside chat at 11:50am ET. The webcast link will be available in the "IR C

eClinicalWorks®, the largest ambulatory cloud EHR, today announced that First Choice Neurology has selected the first-of-its-kind, EHR-agnostic, AI-powered contact center solution healow® Genie, to improve patient engagement. The intelligent assistant offers patients 24/7 access to vital health information via voice call, text, or chatbot. With 63 locations across Florida, First Choice Neurology stands as the state's largest and most prominent neurology center. As it has experienc

Encompass Health Corp.today announced it will participate in the Barclays Global Healthcare Conference, which is being held March 11-13, 2025. A live webcast of the presentation by Encompass Health's President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will be available at http://investor.encompasshealth.com on Tuesday, March 11, 2025, from 8:30–8:55 a.m. ET. About Encompass Health:

ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for surgically treating nearsightedness, with or without astigmatism. The latest generation of femtosecond lasers from ZEISS enters the China market at a time when more than 10 million eyes have been treated with ZEISS SMILE and SMILE pro worldwide, reflecting the technology's broad global momentum driven by st

Dassault Systèmes  today announced that a beta test is underway to evaluate a new generation of the Living Heart model that can be highly customized for individual patients or patient populations. The test aims to deliver a level of configuration and automation that makes the model a powerful resource to simplify medical device research and development, and accelerate the testing and regulatory approval of new treatments. Members of the Living Heart Project are testing t